Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Skolnik, MD
Inovio Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Christiana Care Health Systems
Newark, Delaware, United States
- Augusta University
Augusta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Maine Medical Center
Scarborough, Maine, United States
- University of Michigan
Ann Arbor, Michigan, United States
- St. Dominic Hospital
Jackson, Mississippi, United States
- Rutgers New Jersey
Newark, New Jersey, United States
- Columbia University Medical Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Lyndhurst Clinical Research
Winston-Salem, North Carolina, United States
- Complete Healthcare for Women, Inc.
Columbus, Ohio, United States
- University of Pittsburgh Medical Center - Magee Womens Hospital
Pittsburgh, Pennsylvania, United States
- Chattanooga'S Program in Women'S Oncology
Chattanooga, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2017
- Primary completion
- 23 Jul 2020
- Completion
- 18 Dec 2020
- Last update posted
- 25 Aug 2023
- Registered enrollment
- 33
- Registry id
- NCT03180684
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.